Clinical trial
Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical
NCT07815054 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- September 30, 2029
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma (hcc)